SEC Form 4 research
| Issuer | Definium Therapeutics, Inc. |
|---|---|
| Tickers | MNMD, DFTX |
| Reporting owners | 18 |
| Officers and directors | 8 |
| Last public filing | 2026-09-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-29 | 2026-09-25 | Karlin Daniel | S | 10,853 | $36.57 | Not reported |
| 2026-09-29 | 2026-09-25 | Barrow Robert | S | 31,550 | $36.57 | Not reported |
| 2026-09-29 | 2026-09-25 | Wiley Matthew T. | S | 3,097 | $36.57 | Not reported |
| 2026-09-29 | 2026-09-25 | Sullivan Mark | S | 14,051 | $36.57 | Not reported |
| 2026-09-29 | 2026-09-25 | Roberts Brandi | S | 3,377 | $36.57 | Not reported |
| 2026-09-14 | 2026-09-14 | Karlin Daniel | A | 200,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-14 | Wiley Matthew T. | A | 125,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-14 | Sullivan Mark | A | 125,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-14 | Roberts Brandi | A | 125,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-14 | Barrow Robert | A | 750,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.